Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OssDsign ABOSTO:OSSD +3.04%58 Receivables Turnover is 1.54 as of Mar. 2026. GuruFocus rates OSTO:OSSD with a GF Score™ of 58/100 and a GF Value™ of kr11.14 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 813 Medical Devices & Instruments companies, OssDsign AB ranks better than 67.77% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. OssDsign AB's Revenue for the
three
months ended in Mar. 2026 was kr36.9 Mil. OssDsign AB's average Accounts Receivable for the
three
months ended in Mar. 2026 was kr23.9 Mil.
Hence, OssDsign AB's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.54.
OssDsign AB (OSTO:OSSD) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
OssDsign AB Receivables Turnover Related Terms
OssDsign AB Receivables Turnover Historical Data
* Premium members only.
The historical data trend for OssDsign AB's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:OSSD vs ABT, SYK, MDT: Receivables Turnover Comparison
For the Medical Devices subindustry, OssDsign AB's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OssDsign AB Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, OssDsign AB's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where OssDsign AB's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OssDsign AB (OSTO:OSSD) has a Receivables Turnover of 1.54 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on OssDsign AB and its competitors. According to the industry distribution chart, OssDsign AB ranks #262 out of 813 companies in the Medical Devices & Instruments industry, placing it in the top 32.2%.
Is OssDsign AB's Receivables Turnover too high?
OssDsign AB's current Receivables Turnover is 1.54. The Medical Devices & Instruments industry median Receivables Turnover is 5.51. OssDsign AB's value of 1.54 is 72.1% below this industry median. Based on the distribution chart, OssDsign AB ranks #262 out of 813 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, OssDsign AB has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does OssDsign AB's Receivables Turnover compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, OssDsign AB ranks #262 out of 813 companies for Receivables Turnover. This puts OssDsign AB in the upper half of its industry. The industry median Receivables Turnover is 5.51. OssDsign AB's value of 1.54 is 72.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.51, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OssDsign AB's current Receivables Turnover of 1.54 is 72.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on OssDsign AB and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OssDsign AB's current Receivables Turnover is 1.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OssDsign AB stock overvalued right now?
Based on GuruFocus' analysis, OssDsign AB (OSTO:OSSD) is currently considered Possible Value Trap. The stock's GF Value™ is kr11.14, compared to a current price of kr4.24 — trading 62% below its estimated fair value. The current Receivables Turnover is 1.54 and 72.1% below the Medical Devices & Instruments industry median of 5.51. OssDsign AB's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For OssDsign AB (OSTO:OSSD), the current Receivables Turnover is 1.54 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OssDsign AB (OSTO:OSSD) Overvalued in 2026?
Based on GuruFocus' analysis, OssDsign AB stock appears to be undervalued.
The current stock price of kr4.24 is trading 62% below its estimated GF Value™ of kr11.14.
GuruFocus considers OssDsign AB to be Possible Value Trap.
Key valuation signals for OSTO:OSSD:
Receivables Turnover: 1.54
GF Value™: kr11.14 vs. price of kr4.24 (62% below fair value)
Industry Position: 72.1% below the Medical Devices & Instruments median (#262 of 813)
No single metric tells the full story. See the OSTO:OSSD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OssDsign AB is a developer and international provider of next-generation orthobiologics products. The company's product OssDsign Catalyst is a bone graft that stimulates the formation of healthy bone tissue in spinal fusion surgeries. Geographically the company generates revenue from the USA, Germany, Sweden and UK. The company generates the majority of its revenue from the USA region.
58GF Score
Get the complete analysis for OSTO:OSSD
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:OSSD has been successfully added to your 
